Malta - English - Medicines Authority

chiesi espana s.a. c/berlin 38-48. 7 planta 08029. barcelona, spain - calcium pantothenate, cyanocobalamin, panax ginseng, nicotinamide, pyridoxine hydrochloride, thiamine hydrochloride, riboflavin sodium, phosphate - oral solution - calcium pantothenate 21.83 mg cyanocobalamin 0.01 mg panax ginseng 150 mg nicotinamide 20 mg pyridoxine hydrochloride 3.03 mg thiamine hydrochloride 2.24 mg riboflavin sodium phosphate 2.73 mg - tonics

Malta - English - Medicines Authority

chiesi espana s.a. c/berlin 38-48. 7 planta 08029. barcelona, spain - doxycycline - hard capsule - doxycycline 100 mg - antibacterials for systemic use

Malta - English - Medicines Authority

chiesi espana s.a. c/berlin 38-48. 7 planta 08029. barcelona, spain - etofenamate - gel - etofenamate 50 mg/g - topical products for joint and muscular pain

Malta - English - Medicines Authority

chiesi espana s.a. c/berlin 38-48. 7 planta 08029. barcelona, spain - etofenamate - cutaneous spray, solution - etofenamate 50 mg/ml - topical products for joint and muscular pain

European Union - English - EMA (European Medicines Agency)

chiesi farmaceutici s.p.a. - formoterol fumarate dihydrate, glycopyrronium, beclometasone dipropionate - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist (for effects on symptoms control and prevention of exacerbations see section 5.1).

United Kingdom - English - myHealthbox

chiesi limited - felodipine - prolonged-release tablet - 5 mg - in the management of hypertension and prophylaxis of chronic stable angina pectoris

United Kingdom - English - myHealthbox

chiesi limited - felodipine - prolonged-release tablet - 10 mg - in the management of hypertension and prophylaxis of chronic stable angina pectoris

United Kingdom - English - myHealthbox

chiesi limited - salbutamol sulfate - modified release capsules, hard - 4.80mg - selective beta2 -adrenoceptor agonists for systemic use - continuous symptomatic treatment of asthma and other types of reversible obstructive airways disease

United Kingdom - English - myHealthbox

chiesi limited - salbutamol sulfate - modified release capsules, hard - 9.60mg - selective beta2 -adrenoceptor agonists for systemic use - continuous symptomatic treatment of asthma and other types of reversible obstructive airways disease

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

chiesi ltd - caffeine citrate - solution for infusion - 20mg/1ml